rs144832924
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_032444.4(SLX4):c.85C>T(p.Arg29Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000592 in 1,614,152 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R29H) has been classified as Likely benign.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group PInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLX4 | NM_032444.4 | c.85C>T | p.Arg29Cys | missense_variant | Exon 2 of 15 | ENST00000294008.4 | NP_115820.2 | |
| SLX4 | XM_024450471.2 | c.85C>T | p.Arg29Cys | missense_variant | Exon 2 of 15 | XP_024306239.1 | ||
| SLX4 | XM_011522715.4 | c.85C>T | p.Arg29Cys | missense_variant | Exon 2 of 15 | XP_011521017.1 | ||
| SLX4 | XR_007064923.1 | n.734C>T | non_coding_transcript_exon_variant | Exon 2 of 13 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLX4 | ENST00000294008.4 | c.85C>T | p.Arg29Cys | missense_variant | Exon 2 of 15 | 5 | NM_032444.4 | ENSP00000294008.3 | ||
| SLX4 | ENST00000466154.5 | n.380C>T | non_coding_transcript_exon_variant | Exon 1 of 7 | 1 | |||||
| SLX4 | ENST00000486524.1 | n.713C>T | non_coding_transcript_exon_variant | Exon 2 of 4 | 2 | |||||
| SLX4 | ENST00000697859.1 | n.707C>T | non_coding_transcript_exon_variant | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.000736 AC: 112AN: 152148Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000771 AC: 194AN: 251460 AF XY: 0.000750 show subpopulations
GnomAD4 exome AF: 0.000577 AC: 843AN: 1461886Hom.: 1 Cov.: 31 AF XY: 0.000584 AC XY: 425AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000736 AC: 112AN: 152266Hom.: 1 Cov.: 32 AF XY: 0.000940 AC XY: 70AN XY: 74458 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Fanconi anemia Benign:2
- -
- -
not specified Uncertain:1
This sequence change does not appear to have been previously described in patients with SLX4-related disorders and has been described in the gnomAD database with a relatively high population frequency of 0.49% in the Finnish subpopulation (dbSNP rs144832924). The p.Arg29Cys change affects a poorly conserved amino acid residue located in a domain of the SLX4 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg29Cys substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Arg29Cys change remains unknown at this time. -
Fanconi anemia complementation group P Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at